Kenalog 10 Injection (Triamcinolone Acetonide) 10 mg/ml Multi Dose Vial 5 mL (Rx)


Kenalog 10 for Injection contains the active ingredient triamcinolone acetonide, which is a synthetic corticosteroid. It is used to treat a variety of conditions, including allergies, arthritis, hormonal disorders, skin problems, and certain types of cancer. Specifically, it may be used to help reduce inflammation and swelling in the body, relieve pain, and suppress the immune system. It may also be used for diagnostic purposes in certain medical procedures. It is only available through a prescription and should be used under the guidance of a healthcare provider.
Kenalog 10 Injection (triamcinolone acetonide) is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Kenalog 10 is usually given in these conditions as a short-term treatment of a severe or aggravated episode.
Benefits of Kenalog 10 mg for Injection
Brand: Bristol Myers Squibb
Size: 5 mL
NDC: 00003-0494-20
UPC: 300030494207
Kenalog 10 (Triamcinolone Acetonide) is a powerful corticosteroid usually administered to treat a variety of medical conditions, including asthma, skin inflammation, ulcerative colitis, arthritis, and certain eye conditions. Kenalog 10 mg is available for injection in a 5 ml multi-dose vial, commonly prescribed for intramuscular injection. Common side effects of Kenalog 10 mg include swelling, redness, irritation, or burning at the site of the injection. As with all medications, it is important to follow the instructions of your doctor carefully and to speak to a doctor about any side effects you may experience. Kenalog 10 mg should be administered carefully and should only be used on the advice of a physician.
| Attribute | Detail |
|---|---|
| Generic name | Triamcinolone acetonide injectable suspension, USP |
| Brand name | Kenalog-10 |
| Manufacturer | Bristol Myers Squibb |
| Concentration | 10 mg/mL |
| Vial size | 5 mL multi-dose vial |
| Total dose per vial | 50 mg (5 mL × 10 mg/mL) |
| Preservative | Benzyl alcohol |
| Storage | Controlled room temperature 20–25°C (68–77°F) — do not refrigerate or freeze |
| Approved routes | Intra-articular; intralesional |
| Prohibited routes | IV, IM, intraocular, epidural, intrathecal |
| Prescription status | Rx only |
| Drug class | Corticosteroid — glucocorticoid |
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
For Licensed Healthcare Professionals Only. Kenalog-10 Injection (Triamcinolone Acetonide, 10 mg/mL) is a prescription-only (Rx) pharmaceutical product regulated under US federal law. Purchase is restricted to individuals and entities holding a valid US medical, pharmacy, veterinary, or other applicable professional licence. Mountainside Medical Equipment is not authorised to supply this product to unlicensed individuals.
The clinical and pharmacological information provided on this page is intended as a general reference for qualified healthcare professionals and is based on the FDA-approved prescribing information for Kenalog-10 Injection as published by Bristol Myers Squibb. This content does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information, which should be reviewed in its entirety before clinical use.
All dosing, administration, and clinical usage decisions must be made by a licensed healthcare provider based on the individual patient's clinical presentation, medical history, and current prescribing information. Mountainside Medical Equipment makes no representations regarding patient outcomes.
Product specifications, availability, and pricing are subject to change without notice. For the most current prescribing information, refer to the FDA DailyMed database at dailymed.nlm.nih.gov or contact Bristol Myers Squibb directly.
Yes. Kenalog-10 is the brand name for triamcinolone acetonide injectable suspension, USP, manufactured by Bristol Myers Squibb at a concentration of 10 mg/mL. Triamcinolone acetonide is the active pharmaceutical ingredient (INN). When prescribers or procurement teams reference triamcinolone injection 10 mg/mL, they are referring to this product or its generic equivalents.
Kenalog-10 is indicated for two categories of injection: intra-articular and soft tissue injection for inflammatory joint conditions (including acute gouty arthritis, bursitis, tenosynovitis, epicondylitis, rheumatoid arthritis, and osteoarthritis synovitis), and intralesional injection for dermatologic conditions including keloids, alopecia areata, psoriatic plaques, and discoid lupus erythematosus. It is not indicated for systemic corticosteroid therapy or intramuscular administration.
No. Kenalog-10 is explicitly labelled for intra-articular and intralesional use only. The FDA-approved prescribing information states: 'NOT FOR INTRAVENOUS, INTRAMUSCULAR, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE.' Kenalog-40 (triamcinolone acetonide 40 mg/mL) is the formulation approved for intramuscular administration where systemic corticosteroid therapy is required.
Both are triamcinolone acetonide manufactured by Bristol Myers Squibb, but they differ in concentration, approved routes, and clinical applications. Kenalog-10 (10 mg/mL) is approved only for intra-articular and intralesional injection and is the preferred concentration for intralesional use due to its lower atrophy risk at skin injection sites. Kenalog-40 (40 mg/mL) is approved for intramuscular administration as well as intra-articular injection, and is used when systemic corticosteroid effect is needed. The two are not interchangeable.
ILK stands for intralesional Kenalog — a clinical shorthand for the technique of injecting triamcinolone acetonide directly into a skin lesion. It is routinely used by dermatologists and aesthetic clinicians to treat keloids, hypertrophic scars, alopecia areata patches, and psoriatic or lichen planus plaques. The 10 mg/mL concentration of Kenalog-10 is the standard choice for ILK procedures, typically administered in small volumes (0.05–0.2 mL per injection point) using a 23–25 gauge needle.
Mountainside Medical offers Kenalog-10 at competitive wholesale pricing for licensed healthcare buyers. Volume pricing is available for bulk institutional orders. New accounts receive 5% off their first purchase. For current pricing and bulk order enquiries, contact the sales team at sales@mountainside-medical.com or call +1 (888) 687-4334. Free shipping applies to all US orders over $100.
Yes, licensed healthcare professionals and institutional buyers can purchase Kenalog-10 through Mountainside Medical. As a prescription-only (Rx) product, a valid US medical or professional licence is required. Mountainside Medical verifies licence credentials as part of the ordering process. Unlicensed individuals cannot purchase this product.
Yes. Kenalog-10 is a corticosteroid — specifically a synthetic glucocorticoid in the same class as cortisone, dexamethasone, and methylprednisolone. It works by binding to glucocorticoid receptors and suppressing pro-inflammatory cytokine transcription, which reduces local swelling, pain, and immune activity at the injection site. It is not an anabolic steroid.
Kenalog-10 should be stored at controlled room temperature between 20–25°C (68–77°F). Do not refrigerate or freeze. The product contains benzyl alcohol as a preservative, and cold temperatures can cause the suspension particles to agglomerate. Vials should be shaken vigorously before each use to ensure uniform suspension, and any vial showing persistent clumping after shaking should be discarded.
The HCPCS code for triamcinolone acetonide injection, not otherwise specified, 10 mg is J3301. This corresponds directly to the queries 'injection, triamcinolone acetonide, not otherwise specified, 10 mg' and 'injection triamcinolone acetonide nos 10 mg' used in billing and procurement documentation. Confirm current coding with your billing team, as HCPCS codes are subject to annual CMS updates.
Kenalog 10 for Injection contains the active ingredient triamcinolone acetonide, which is a synthetic corticosteroid. It is used to treat a variety of conditions, including allergies, arthritis, hormonal disorders, skin problems, and certain types of cancer. Specifically, it may be used to help reduce inflammation and swelling in the body, relieve pain, and suppress the immune system. It may also be used for diagnostic purposes in certain medical procedures. It is only available through a prescription and should be used under the guidance of a healthcare provider.
Kenalog 10 Injection (triamcinolone acetonide) is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Kenalog 10 is usually given in these conditions as a short-term treatment of a severe or aggravated episode.
Benefits of Kenalog 10 mg for Injection
Brand: Bristol Myers Squibb
Size: 5 mL
NDC: 00003-0494-20
UPC: 300030494207
Kenalog 10 (Triamcinolone Acetonide) is a powerful corticosteroid usually administered to treat a variety of medical conditions, including asthma, skin inflammation, ulcerative colitis, arthritis, and certain eye conditions. Kenalog 10 mg is available for injection in a 5 ml multi-dose vial, commonly prescribed for intramuscular injection. Common side effects of Kenalog 10 mg include swelling, redness, irritation, or burning at the site of the injection. As with all medications, it is important to follow the instructions of your doctor carefully and to speak to a doctor about any side effects you may experience. Kenalog 10 mg should be administered carefully and should only be used on the advice of a physician.
| Attribute | Detail |
|---|---|
| Generic name | Triamcinolone acetonide injectable suspension, USP |
| Brand name | Kenalog-10 |
| Manufacturer | Bristol Myers Squibb |
| Concentration | 10 mg/mL |
| Vial size | 5 mL multi-dose vial |
| Total dose per vial | 50 mg (5 mL × 10 mg/mL) |
| Preservative | Benzyl alcohol |
| Storage | Controlled room temperature 20–25°C (68–77°F) — do not refrigerate or freeze |
| Approved routes | Intra-articular; intralesional |
| Prohibited routes | IV, IM, intraocular, epidural, intrathecal |
| Prescription status | Rx only |
| Drug class | Corticosteroid — glucocorticoid |
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
For Licensed Healthcare Professionals Only. Kenalog-10 Injection (Triamcinolone Acetonide, 10 mg/mL) is a prescription-only (Rx) pharmaceutical product regulated under US federal law. Purchase is restricted to individuals and entities holding a valid US medical, pharmacy, veterinary, or other applicable professional licence. Mountainside Medical Equipment is not authorised to supply this product to unlicensed individuals.
The clinical and pharmacological information provided on this page is intended as a general reference for qualified healthcare professionals and is based on the FDA-approved prescribing information for Kenalog-10 Injection as published by Bristol Myers Squibb. This content does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information, which should be reviewed in its entirety before clinical use.
All dosing, administration, and clinical usage decisions must be made by a licensed healthcare provider based on the individual patient's clinical presentation, medical history, and current prescribing information. Mountainside Medical Equipment makes no representations regarding patient outcomes.
Product specifications, availability, and pricing are subject to change without notice. For the most current prescribing information, refer to the FDA DailyMed database at dailymed.nlm.nih.gov or contact Bristol Myers Squibb directly.
Yes. Kenalog-10 is the brand name for triamcinolone acetonide injectable suspension, USP, manufactured by Bristol Myers Squibb at a concentration of 10 mg/mL. Triamcinolone acetonide is the active pharmaceutical ingredient (INN). When prescribers or procurement teams reference triamcinolone injection 10 mg/mL, they are referring to this product or its generic equivalents.
Kenalog-10 is indicated for two categories of injection: intra-articular and soft tissue injection for inflammatory joint conditions (including acute gouty arthritis, bursitis, tenosynovitis, epicondylitis, rheumatoid arthritis, and osteoarthritis synovitis), and intralesional injection for dermatologic conditions including keloids, alopecia areata, psoriatic plaques, and discoid lupus erythematosus. It is not indicated for systemic corticosteroid therapy or intramuscular administration.
No. Kenalog-10 is explicitly labelled for intra-articular and intralesional use only. The FDA-approved prescribing information states: 'NOT FOR INTRAVENOUS, INTRAMUSCULAR, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE.' Kenalog-40 (triamcinolone acetonide 40 mg/mL) is the formulation approved for intramuscular administration where systemic corticosteroid therapy is required.
Both are triamcinolone acetonide manufactured by Bristol Myers Squibb, but they differ in concentration, approved routes, and clinical applications. Kenalog-10 (10 mg/mL) is approved only for intra-articular and intralesional injection and is the preferred concentration for intralesional use due to its lower atrophy risk at skin injection sites. Kenalog-40 (40 mg/mL) is approved for intramuscular administration as well as intra-articular injection, and is used when systemic corticosteroid effect is needed. The two are not interchangeable.
ILK stands for intralesional Kenalog — a clinical shorthand for the technique of injecting triamcinolone acetonide directly into a skin lesion. It is routinely used by dermatologists and aesthetic clinicians to treat keloids, hypertrophic scars, alopecia areata patches, and psoriatic or lichen planus plaques. The 10 mg/mL concentration of Kenalog-10 is the standard choice for ILK procedures, typically administered in small volumes (0.05–0.2 mL per injection point) using a 23–25 gauge needle.
Mountainside Medical offers Kenalog-10 at competitive wholesale pricing for licensed healthcare buyers. Volume pricing is available for bulk institutional orders. New accounts receive 5% off their first purchase. For current pricing and bulk order enquiries, contact the sales team at sales@mountainside-medical.com or call +1 (888) 687-4334. Free shipping applies to all US orders over $100.
Yes, licensed healthcare professionals and institutional buyers can purchase Kenalog-10 through Mountainside Medical. As a prescription-only (Rx) product, a valid US medical or professional licence is required. Mountainside Medical verifies licence credentials as part of the ordering process. Unlicensed individuals cannot purchase this product.
Yes. Kenalog-10 is a corticosteroid — specifically a synthetic glucocorticoid in the same class as cortisone, dexamethasone, and methylprednisolone. It works by binding to glucocorticoid receptors and suppressing pro-inflammatory cytokine transcription, which reduces local swelling, pain, and immune activity at the injection site. It is not an anabolic steroid.
Kenalog-10 should be stored at controlled room temperature between 20–25°C (68–77°F). Do not refrigerate or freeze. The product contains benzyl alcohol as a preservative, and cold temperatures can cause the suspension particles to agglomerate. Vials should be shaken vigorously before each use to ensure uniform suspension, and any vial showing persistent clumping after shaking should be discarded.
The HCPCS code for triamcinolone acetonide injection, not otherwise specified, 10 mg is J3301. This corresponds directly to the queries 'injection, triamcinolone acetonide, not otherwise specified, 10 mg' and 'injection triamcinolone acetonide nos 10 mg' used in billing and procurement documentation. Confirm current coding with your billing team, as HCPCS codes are subject to annual CMS updates.
You need an account to add products to your wishlist. Log in or create an account to start saving your favorites.